Evidence map›Paper›PMID 39843930›Full record

ArticleScientific reports2025

Detection and genomic characterisation of foot-and-mouth disease virus serotypes circulating in Cameroon using environmental sampling.

Claire Colenutt, Andrew Shaw, Seraphine Nkie Esemu, Achah Jerome Kfusi, Bessong Willington Ojong, Emma Brown, Jemma Wadsworth, Nick J Knowles, Donald P King, Lucy Mande Ndip and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Claire Colenutt *The Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK.
Andrew Shaw *The Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK. andrew.shaw@pirbright.ac.uk.
Seraphine Nkie EsemuLaboratory for Emerging Infectious Disease, University of Buea, Buea, Cameroon.
Achah Jerome KfusiLaboratory for Emerging Infectious Disease, University of Buea, Buea, Cameroon.
Bessong Willington OjongEuropean Commission for the Control of Foot-and-Mouth Disease (EuFMD), Food and Agriculture Organisation of the United Nations (FAO), Rome, Italy.
Emma BrownThe Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK.
Jemma WadsworthThe Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK.
Nick J KnowlesThe Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK.
Donald P KingThe Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK.
Lucy Mande NdipLaboratory for Emerging Infectious Disease, University of Buea, Buea, Cameroon.
Etienne ChevanneEuropean Commission for the Control of Foot-and-Mouth Disease (EuFMD), Food and Agriculture Organisation of the United Nations (FAO), Rome, Italy.
Fabrizio RossoThe Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK.
Keith SumptionThe Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK.
Simon GubbinsThe Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK.

Funding

Biotechnology and Biosciences Research Council (BBSRC) BBS/E/I/00007036Department for the Environment, Food and Rural Affairs SE2816Department for the Environment, Food and Rural Affairs SE2945
6 · The paper itself

Abstract

Foot-and-mouth disease virus (FMDV) is a highly contagious, economically important disease of livestock and wildlife species. Active monitoring and understanding the epidemiology of FMDV underpin the foundations of control programmes. In many endemic areas, however, veterinary resources are limited, resulting in a requirement for simple sampling techniques to increase and supplement surveillance efforts. In this study, environmental sampling was used for the first time at livestock markets and abattoirs across Cameroon to assess the opportunities for broad scale, non-invasive disease surveillance at such sites. Environmental samples (n = 1994) were collected from six locations across Cameroon between May and July 2019. Concurrent with environmental sampling, a questionnaire was used to gather descriptive information on the use and practices of market and abattoir sites. Samples were screened for the presence of FMDV RNA using a pan-serotype FMDV specific real-time RT-PCR assay. Positive samples were characterised at the genomic level using next generation sequencing in combination with a novel probe-based enrichment strategy. A total of 173/1994 (8.68%) environmental samples were found to be positive for FMDV RNA. Genome length sequences were obtained from environmental samples, with phylogenetically relevant capsid sequences obtained from 14 samples, with representatives of serotypes O (n = 6), A (n = 7) and SAT 2 (n = 3). The questionnaire results revealed that animals in Cameroon can be transported long distances to markets and abattoirs, with varying levels of control and biosecurity practices in place. The approaches used in this study have highlighted that environmental sampling is an effective and non-invasive approach to assessing FMDV presence. Furthermore, the study has demonstrated that livestock markets, abattoirs and trucks could be targeted for the introduction of biosecurity interventions as well as providing opportunities for carrying out disease surveillance. Information resulting from such surveillance could provide valuable knowledge of circulating viruses within a region of interest, aiding strategic approaches for surveillance and control of FMDV.

Indexed as

Foot-and-Mouth DiseaseFoot-and-Mouth Disease VirusGenome, ViralAbattoirsAnimalsCameroonLivestockPhylogenyRNA, ViralSerogroupRNA, Viral

Identifiers

PMID39843930
PMCPMC11882811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.